Trial Review

The ANZCTR website will be unavailable from 1pm until 3pm (AEDT) on Wednesday the 30th of October for website maintenance. Please be sure to log out of the system in order to avoid any loss of data.

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been endorsed by the ANZCTR. Before participating in a study, talk to your health care provider and refer to this information for consumers
Trial details imported from ClinicalTrials.gov

For full trial details, please see the original record at https://clinicaltrials.gov/study/NCT02154295




Registration number
NCT02154295
Ethics application status
Date submitted
16/05/2014
Date registered
3/06/2014
Date last updated
14/12/2020

Titles & IDs
Public title
In Vitro and In Vivo Comparison Between Intravascular Ultrasound (IVUS) Systems
Scientific title
Simultaneous Acquisition of Intravascular Ultrasound and Near Infrared Spectroscopy Data in the Coronary Artery Study
Secondary ID [1] 0 0
0126
Universal Trial Number (UTN)
Trial acronym
SAVOIR2
Linked study record

Health condition
Health condition(s) or problem(s) studied:
Coronary Artery Disease 0 0
Condition category
Condition code
Cardiovascular 0 0 0 0
Coronary heart disease

Intervention/exposure
Study type
Interventional
Description of intervention(s) / exposure
Active comparator: Eagle Eye Platinum - Eagle Eye Platinum Catheter as the comparator.

Active comparator: Revolution - Revolution Catheter as the comparator

Active comparator: TVC Insight 40MHz - TVC Insight as comparative catheter.

Active comparator: Atlantis Pro - Atlantis Pro catheter as comparator
Comparator / control treatment
Control group

Outcomes
Primary outcome [1] 0 0
Clarity of Image and ease of interpretation as measured by physician survey
Timepoint [1] 0 0
Day 0
Secondary outcome [1] 0 0
Comparison of diameters and areas using ultrasound imaging from a standard test fixture(model) and test catheters
Timepoint [1] 0 0
Day 0

Eligibility
Key inclusion criteria
* =18 years of age
* Scheduled for a coronary angiogram at the Royal Adelaide Hospital.
* Women must be non-lactating or not of childbearing potential (1 year post menopausal or surgically sterilized [total hysterectomy, bilateral tubal ligation, bilateral oophorectomy]).
* Target artery must be >2 mm to accommodate the IVUS catheter.
* IVUS must be clinically indicated or indeterminate angiographic lesion in the artery (40%-70% angiographic stenosis)
Minimum age
18 Years
Maximum age
No limit
Sex
Both males and females
Can healthy volunteers participate?
No
Key exclusion criteria
* Cardiogenic shock
* Contraindications to intracoronary nitroglycerin (hypertrophic obstructive cardiomyopathy; cerebral hemorrhage, head trauma; concomitant sildenafil, tadalafil or vardenafil use)
* Known coronary artery spasm
* Significant bleeding risk (i.e. previous hemorrhagic stroke, active peptic ulcer disease)
* Bleeding diathesis
* Significant renal impairment (patients will be excluded if their calculated creatinine clearance is < 30 mL/min)

Study design
Purpose of the study
Other
Allocation to intervention
Non-randomised trial
Procedure for enrolling a subject and allocating the treatment (allocation concealment procedures)
Methods used to generate the sequence in which subjects will be randomised (sequence generation)
Masking / blinding
Open (masking not used)
Who is / are masked / blinded?



Intervention assignment
Parallel
Other design features
Phase
NA
Type of endpoint/s
Statistical methods / analysis

Recruitment
Recruitment status
Completed
Data analysis
Reason for early stopping/withdrawal
Other reasons
Date of first participant enrolment
Anticipated
Actual
1/05/2014
Date of last participant enrolment
Anticipated
Actual
Date of last data collection
Anticipated
Actual
1/08/2014
Sample size
Target
Accrual to date
Final
16
Recruitment in Australia
Recruitment state(s)
SA
Recruitment hospital [1] 0 0
Royal Adelaide Hospital - Adelaide
Recruitment postcode(s) [1] 0 0
5000 - Adelaide

Funding & Sponsors
Primary sponsor type
Commercial sector/industry
Name
Infraredx
Address
Country
Other collaborator category [1] 0 0
Other
Name [1] 0 0
South Australian Health and Medical Research Institute
Address [1] 0 0
Country [1] 0 0
Other collaborator category [2] 0 0
Other
Name [2] 0 0
Royal Adelaide Hospital
Address [2] 0 0
Country [2] 0 0

Ethics approval
Ethics application status

Summary
Brief summary
Trial website
Trial related presentations / publications
Public notes

Contacts
Principal investigator
Name 0 0
Samuel Sidharta, MBBS BMedSc
Address 0 0
Royal Adelaide Hospital
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for public queries
Name 0 0
Address 0 0
Country 0 0
Phone 0 0
Fax 0 0
Email 0 0
Contact person for scientific queries

No information has been provided regarding IPD availability


What supporting documents are/will be available?

No Supporting Document Provided



Results publications and other study-related documents

No documents have been uploaded by study researchers.

Results not provided in https://clinicaltrials.gov/study/NCT02154295